Most Read Articles
6 days ago
Among patients with rheumatoid arthritis, those who are obese are more likely to have worse disease activity, lower functional ability and poorer health-related quality of life compared with their nonobese counterparts, a study has found.
30 May 2016
Good glycaemic control and minimizing CV risk factors are the cornerstones of T2D management. Empagliflozin, a SGLT2 inhibitor, has a unique mechanism of action that not only lowers plasma glucose but also other CV risk factors. The EMPA-REG OUTCOME® trial explored the CV benefits of this drug, and a panel of eminent speakers gathered recently to present the implications of this study and empagliflozin on clinical practice.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.

Physical activity confers benefits for T2DM therapy-related quality of life

13 Mar 2018

High levels of physical activity are associated with good therapy-related quality-of-life (QOL) scores among type 2 diabetes mellitus (T2DM) patients, a study suggests.

Researchers analysed cross-sectional data from 2,970 patients with T2DM (mean age 65.8 years; mean BMI, 24.7 kg/m2; mean HbA1c level, 7.6 percent [58.7 mmol/mol]) in a Japanese diabetes registry. They estimated correlations between diabetes therapy-related quality of life (DTR-QOL; domains 1–4) and physical activity levels using logistic regression.

In univariate models, physical activity levels were significantly associated with scores for DTR-QOL domains 1 (p=0.0046), 2 (p=0.0004) and 4 (p<0.001), but not domain 3 (p=0.5073).

In multivariable models, the association of high physical activity levels with DTR-QOL scores was seen for domains 1 (quartiles 2–4 vs quartile 1 of physical activity: odds ratios [ORs], 1.16, 1.56 and 1.22, respectively; p=0.032) 3 (ORs, 1.45, 1.55 and 1.38; p=0.049) and 4 (ORs, 1.09, 1.30 and 1.51; p=0.001), but not domain 2 (ORs, 1.19, 1.26 and 1.23; p=0.096).

Researchers noted that choosing diabetes therapy might be associated with attaining high QOL levels, with higher QOL leading to more physical activity, and more physical activity, in turn, resulting in preference to avoid medicines that increase likelihood of hypoglycaemia.

Treatment guidelines highlight the importance and effectiveness of including physical activity in T2DM therapeutic strategies. Nevertheless, adherence to long-term physical activity may be perceived as a burden, which could have a negative effect on health-related QOL despite improved clinical outcomes. [Diabetologia 2012;55:1577-1596]

It is thus important to identify factors associated with improved adherence to physical activity therapy, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Among patients with rheumatoid arthritis, those who are obese are more likely to have worse disease activity, lower functional ability and poorer health-related quality of life compared with their nonobese counterparts, a study has found.
30 May 2016
Good glycaemic control and minimizing CV risk factors are the cornerstones of T2D management. Empagliflozin, a SGLT2 inhibitor, has a unique mechanism of action that not only lowers plasma glucose but also other CV risk factors. The EMPA-REG OUTCOME® trial explored the CV benefits of this drug, and a panel of eminent speakers gathered recently to present the implications of this study and empagliflozin on clinical practice.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.